Cervical cancer is caused by a combination of environmental and genetic risk factors.
Introduction
Cervical cancer is the second most common cancer worldwide among women with 493,000 cases reported in year 2002 (1) . The development of cervical cancer is associated with both environmental and genetic risk factors. Infections by sexually transmitted forms of the human papillomavirus (HPV), such as the HPV16 and HPV18, are considered necessary for the development of cervical carcinoma (2, 3) . HPV encode two oncogenic proteins, denoted E6 and E7, which bind to the tumour-suppressor protein 53 (p53) and retinoblastoma protein (pRb) and thereby interfere with the cell cycle control (4, 5) .
Based on the recognition that HPV is the main environmental risk factor for cervical carcinoma, attempts have been made to develop both prophylactic and therapeutic HPV vaccines. The prophylactic HPV vaccines, based on non-infectious virus-like particles (VLPs) show promising results (6, 7) , while it has proven more difficult to develop therapeutic vaccines (8) . A major problem in designing efficient vaccines is the incomplete understanding of the human immune defence against HPV. Cell-mediated immunity (CMI) plays an important role, as is evident from the high prevalence of HPV infection and associated disease in immunosuppressed patients such as those infected with human immunodeficiency virus (HIV) (9) (10) (11) and transplant recipients (12, 13) . In addition, activated cytotoxic T-lymphocytes (CTLs) (14) and HPV16 E6 and E7 specific CTLs (15) have been detected in squamous intraepithelial lesions (SIL) and cervical cancer. HPV specific CTLs has also been found in lymph nodes and tumours of cervical cancer (16) .
Most HPV infections are cleared spontaneously (2) but a small number of women develop persistent infections, indicating that host genetic risk factors affect the outcome of an HPV infection and thereby influence disease development. Persistent HPV infections are associated with high viral load (17, 18) and a high risk of developing malignant cervical epithelial neoplasia (19, 20) . Biological first-degree relatives of cervical tumour patients have an almost 100% higher risk of developing the disease, in comparison to adoptive first-degree relatives of a case (21) . The heritability of the disease is estimated to 27% and the non-shared environmental contribution to 73% (22) . These results indicate that host genetic factors may be important in determining the outcome of an HPV infection. The identification of host genetic risk factors will contribute to an understanding of the aetiology of cervical cancer, such as the immune response to HPV infection, as well as provide general insight in host-pathogen interactions. Susceptibility factor candidates include genes encoding proteins involved in the presentation of foreign antigens, tumour suppression and metabolic pathway enzymes. Their importance has been examined in several case-control studies but the results have often been inconsistent between cohorts. A meta analysis of proposed cervical cancer susceptibility genes shows that only for p53 and the human leukocyte antigen (HLA) class II DQB1 and DRB1 genes were associations confirmed (23) .
An alternative and unprejudiced strategy for identifying genetic risk factors is to scan the genome of familial materials, such as affected sib-pairs (ASPs) or multicase families, with densely spaced markers and search for regions with excess genetic sharing. This linkagebased analysis is a powerful method to identify genes involved in monogenic diseases (24) and has also been successful in mapping loci affecting complex diseases (25) (26) (27) . However, linkage analysis has previously not been used to identify cervical cancer susceptibility loci, due to the lack of suitable family materials. We have identified a population-based cervical cancer material of ASPs, to our knowledge the only material of this kind available for genetic studies (28) . Here, we report findings from the first linkage-based genomewide scan for cervical cancer susceptibility loci using ASPs.
Results

Genotyping of Microsatellites
In the first step of the genome scan, 363 of 387 microsatellites from the Cooperative Human Linkage Center (CHLC)/Weber Human Screening Set Version 6 (Research Genetics) were successfully genotyped. Of these 363 markers, 330 were genotyped in ≥ 95% of the 576 individuals while for 33 markers, 59-94% of the genotypes were obtained. The two markers D17S939 and D17S802, previously linked to EV, a disease with HPV infection aetiology (29) , were genotyped in > 95% of all individuals. In the fine mapping, 116 of 125 microsatellites were successfully genotyped in ≥ 95% of the 576 individuals.
Linkage Analysis of Microsatellites
Nine marker loci located on a total of eight chromosomes (1p36.21, 3q13.12, 4q35.1, 5p15.33, 9q32, 12q24.32, 12q24.33, 16q24.1, 22q11.21) gave a maximum lod-score (MLS) > 1 in single-point and/or multipoint analysis of the ASPs in the first step of the genome scan (Table 1 ). In the single-point analysis, D3S3045 at 3q13.12 yielded a lod-score of MLS > 2 and seven markers (D1S1597, D4S408, D5S392, D9S930, D12S392, D16S539 and D22S446) gave single-point MLS > 1 ( Table 1) . Multipoint MLS calculations reached 1 for four markers (D3S3045, D4S408, D12S392 and GATA32F05) ( Table 1 ). The multipoint MLS were generally lower than single-point lod-scores, but otherwise the results from the two analyses were very similar ( Figure 1 ). No deviation from random allelic sharing was detected for the microsatellites D17S939 and D17S802.
The nine loci on chromosomes 1, 3, 4, 5, 9, 12, 16 and 22 were further studied with additional microsatellites positioned on the deCODE genetic map (30 (Figure 2 A, B and C) . The MLS curve for the 9q32 region was relatively symmetrical and shows one major and one smaller peak. A single peak was found in the MLS curve for the 12q24 region. For the 16q24 locus the MLS curve did not show a narrow peak, but a wider region of elevated MLS. The exact location of candidate region is therefore not possible to determine until additional markers spanning the 16q24 region are identified and genotyped in the ASPs. The evidence of linkage found in the first step of the genomewide scan was not strengthened for 1p36.21, 3q13.12 and 4q35.1 and was reduced for 5p15.33 and 22q11.21 when fine mapping increased marker density (data not shown).
Bioinformatics of Linked Regions
The three regions that gave positive linkage in the fine mapping were searched for genes that have previously been related to diseases with similar characteristics as cervical cancer. Also, two genes in this region, cytochrome b(-245) alpha subunit (CYBA) and core-binding factor alpha subunit 2 translocated to 3 (CBFA2T3), are suggested tumour-suppressor genes (51) . CBFA2T3 is likely to be involved in breast cancer (52) . Table 2 ). These were successfully genotyped in ≥ 95% of the ASPs.
Analysis of TSCOT
Single-point and multipoint nonparametric linkage analysis was performed using the MLS method allowing for dominance variance (54) in the Genehunter 2.1 package (55). The allele frequencies for each marker locus were determined from the ASP material. Table 3) .
Discussion
Cervical carcinoma develops as a result of persistent infection with oncogenic types of HPV (2, 3) . Epidemiological studies suggest that genetic predisposition plays an important role in cervical cancer development (21, 22) . Attempts to identify host genetic factors predisposing to persistent infection and/or cancer development have, with some notable exceptions, proven difficult. The majority of studies have used case-control materials to examine single candidate genes, but have usually lacked sufficient power to detect but quite strong genetic effects (23).
Our search for susceptibility loci, using a genome scan of ASP initially identified nine regions on eight chromosomes with excess allele sharing. Fine mapping with a denser set of microsatellites further strengthened the evidence of linkage for three chromosomal regions, 9q32, 12q24 and 16q24. The lod-scores in these regions reached nominal significance but not the formal threshold for genomewide significant MLS.
It is not unexpected that the MLS for these regions did not reach the level for genomewide significance. Almost all cancer risk alleles identified so far have been highly penetrant and rare, but are unlikely to be responsible for a large proportion of cancer cases (56) . The familial relative risk of cervical cancer in first-degree relatives is about 2 (21), similar to the relative risk of 1.5-2.5 for the most common cancers over all age groups (56) . It is therefore unlikely that we would find common highly penetrant cancer susceptibility genes by linkage analysis in multifactorial diseases. Instead, a substantial fraction of the genetic susceptibility to cervical cancer may be due to genes with weak to moderate effect, similar to the situation for other cancers and complex diseases. A number of factors contribute to the difficulty of identifying susceptibility genes by linkage analysis. Many complex diseases, such as cancer, have a late onset, which makes it difficult to obtain samples from the parental generation. Lack of parental genotypes leads to decreased power for allele sharing methods, since identical by descent (IBD) status has to be inferred from identical by state (IBS) status, leading to reduced precision in estimates of IBD. Loci with minor effects are also difficult to detect by genomewide scans, unless very large family materials are used. Simulations show that in order to have 90% power of detecting a gene with a major effect (λ s > 3.5) in a complex disease by linkage analysis, a minimum of 100 ASPs is required, assuming no recombination between the trait and marker locus (θ=0), completely informative markers, an additive model and a lod-score threshold of 3.0 (57). In reality, multiple loci usually affect the trait, interactions occur among loci (58, 59) , marker density is uneven and usually too low (θ>0) and some markers are not completely informative (57) . Estimates indicate that at least 500 ASPs are needed to detect loci with a moderate effect (1.23 ≤ λ s ≤ 1.39) and sample sizes of 1,000-2,000 pairs may be required to locate genes with small effects (λ s ≤ 1.13) (60).
Since several genes with low to moderate effects are likely to be involved in cervical cancer susceptibility, it will be important to study multilocus models and potential interactions between genes (61). Searching for interactions between multiple loci in genomewide association studies of complex diseases can be both computationally feasible and more powerful than single gene analysis (62) . Modelling of two disease loci at different chromosomal locations, potentially interacting to produce an effect on disease susceptibility, has been performed in analyses of ASPs (58) and statistical methods to detect epistasis in humans have been developed (63) . When software becomes available that can handle genetic interactions between multiple loci in different types of family materials, this should be applied to our ASP material. For example, it will be of interest to examine alleles in HLA class II loci, which are established risk factors for cervical cancer development (28, 64) , in relation to the loci identified in our genome scan.
Our study has found linkage between 9q32, 12q24 and 16q24 and cervical cancer in ASPs. Several candidate genes involved in tumour suppression, inflammation and defence against viral infections are found in these regions. In addition, there are connections between these loci and other human cancers with similar characteristics as cervical carcinoma.
The region surrounding 9q32 is especially interesting since the highest multipoint lod-score (MLS=1.95) in our genomewide scan was found for the markers D9S1856 and D9S930 located in this region. Also several potential genetic candidates, such as TSCOT and DEC1, are located in this region (Figure 3 A) . TSCOT, which maps only 400 Kb from D9S930, is suggested to be involved in antigen and HLA specificity during both thymal development and/or peripheral functions of T-cells (53, 65, 66) . Since cellular immunity mediated by Tlymphocytes is critical for elimination of HPV infected cells (15, 16) and the ability to respond to HPV antigens is related to the capacity of infected cells to present viral epitopes to T-lymphocytes, TSCOT is interesting in relation to disease development. Additional sharing analysis of TSCOT SNPs in the ASPs revealed linkage signals ranging up to MLS=2.40, which further supports that this gene might be involved in cervical cancer susceptibility.
Nevertheless, data from independent association studies as well as functional studies are needed to determine if TSCOT is the actual susceptibility factor. It remains possible that our results reflect LD between the SNPs and the true susceptibility factor in 9q32. For instance, DEC1 is another interesting candidate located ∼400 Kb from D9S1855. DEC1 is often deleted in esophageal cell carcinomas (41) , and in both cervical (2, 3) and esophageal cancer (67) oncogenic HPV types are regarded as prominent risk factors.
At this time, prophylactic HPV vaccines have been successfully produced and are moving into phase III trials (6, 7). However, there are concerns regarding these vaccines with regard to HPV type coverage, duration of protection, potential target age and sex groups and cost effectiveness (68) . In therapeutic vaccine research the focus has been directed towards mapping of HLA class I restricted epitopes of HPV16 and HPV18 E6 and E7 (69, 70) . Such vaccines have proven difficult to develop and peptide vaccination may be most efficient in individuals with pre-invasive disease, who are not immunocompromised and when the HLA genotype of the patient and the HPV genotype of the tumour is known (8) . More knowledge is needed on the immune responses against HPV infections before a successful therapeutic vaccine is likely to become a reality. Further characterisation of genes affecting the immune response against HPV infection and development of persistent infection will thus be important for the development of efficient HPV vaccines.
In summary, our genomewide scan of cervical cancer ASPs has revealed linkage to three chromosomal sites, 9q32, 12q24 and 16q24. Further characterisation of the genetic susceptibility factors for cervical carcinoma, such as TSCOT and other loci located at 9q32, will provide important information for understanding the aetiology of tumour development.
Materials and Methods
Family Material
The Swedish Cancer Registry contains records of all cases of cancer since 1958. In order to identify families with several cases of cervical carcinoma, all cervical tumour cases, classified according to the criteria of the 7 th revision of the International Classification of Diseases, born after 1940 and reported to the Swedish Cancer Registry before 1993, were localized. These individuals were also identified in the Swedish Multi Generation Register (Statistics, Sweden), which resulted in the identification of families with different number of relatives diagnosed with cervical cancer. Among the diagnoses, dysplasia constituted 10%, in situ cervical carcinoma 85% and invasive cervical carcinoma 5% (22) . In total, 1800 ASPs, 2855 affected mother-daughter pairs, 232 families with three cases and eight families with more than three cases were identified in the Swedish population using these registers and search criteria. The sib-pairs and mothers with at least one diagnosis of cervical carcinoma in situ were selected from the 1800 ASPs and these were invited to participate in the study. In total, 4,145 women were invited and blood samples were obtained from 2,135 participants (51%) belonging to 641 ASPs. A set of 278 ASPs, corresponding to 576 individuals, were chosen for the present study. The selection criteria and specific structure of the 278 ASPs has been described previously (28) . The study was approved by the Research Ethics Committee of Uppsala University.
Genotyping of Microsatellites
Extraction of DNA was performed from 4. 
Linkage Analysis of Microsatellites
The allele binning and genotyping was performed using the GeneMapper™ software version 3.0 (Applied Biosystems). To minimise genotyping errors, two scientists performed the genotyping independently. The GAS package, version 2.0 (A. Young, Oxford University) was used to determine inconsistent inheritance.
Qualitative nonparametric linkage analysis was performed using the MLS method (71) . MLS values express deviation of IBD sharing among ASPs and are calculated using a likelihood ratio method with the null hypothesis of mendelian segregation expectations (z 0 =0. (73, 74) . However, these thresholds may be too conservative and an MLS=3.2 is therefore more appropriate to use for genomewide significance when analyzing genetic sharing in ASP materials (75) . In order to ensure that loci with a smaller effect are not 
Bioinformatics of Linked Regions
The regions showing increased MLS scores in the fine mapping analysis were searched for genes and disease associations with apparent connections to cervical cancer pathogenesis using the Ensembl Genome Browser (http://www.ensembl.org/index.html) and the Online Mendelian Inheritance in Man database (OMIM, http://www.ncbi.nlm.nih.gov/Omim/).
Identification of Polymorphisms in TSCOT
The sequence analysis included the promoter region, exons, exon-intron borders, 3'UTR and most of the remaining intron sequences. Primer design was carried out using PrimerExpress® 
Genotyping of Polymorphisms in TSCOT
SNPs were genotyped using either TaqMan® SNP Genotyping or Pyrosequencing™. 
